Logo Labor Publisher

CA 125

Name CA 125
Categories tumour marker
Specimen requirements 1 ml of serum
Procedure remarks Half-life period: 5 days
Clinical utility tumour marker, progress and therapy monitoring with ovarian cancer, early recurrence detection,
suspicions of pancreatic cancer (second marker according to CA 19-9)
Methodology CMIA (chemiluminescence microparticle immunoassay)
Setup schedule and duration Mon. - Fri.
Reference ranges < 35 U/ml